In an unexpected move, Allergan plc divested its global generic business to Teva Pharmaceuticals Industries Ltd. for $40.5 billion, continuing its evolution into an innovative pharma firm. Read More
Though regulatory victory by a competitor is seldom viewed with favor, Esperion Therapeutics Inc.'s harsh treatment on Wall Street in the aftermath of the FDA approval last week of Praluent (alirocumab) may have been overdone, and analysts continued to sift through the fallout Monday. Read More
BOGOTA, Colombia – Biosimilar makers and distributors are looking at the small but growing markets in Latin America to not only reach new consumers, but also pave the way for entry into more developed markets. Read More
HONG KONG– A newly discovered human monoclonal antibody (MAb) that can neutralize several different types of influenza A virus may represent a new antiviral treatment and potentially lead to the development of new more potent vaccines, according to a Chinese study reported in the July 21, 2015, issue of Nature Communications. Read More
Biosimilars developer Oncobiologics Inc. has landed a $31 million financing to support continued expansion and development of its platform and pipeline, which includes clinical-stage biosimilars of Humira (adalimumab, Abbvie Inc.), Avastin (bevacizumab, Roche AG), and nine other preclinical candidates poised to take on off-patent biologics. Read More
The FDA issued a draft guidance on how it intends to collect and use quality metrics to ensure compliance and continuing improvement and innovation in drug and biologic manufacturing. Read More
Leon Nanodrugs GmbH, of Munich, Germany, said it completed the first closing of its series A preferred stock offering at €18.5 million (US$20.55 million). Read More
strong>Ansun Biopharma Inc., of San Diego, said an investigation by the U.S. Attorney's office over the misconduct of the former CEO and chief financial officer (CFO) was dismissed. Read More
Hemostemix Inc., of Calgary, Alberta, disclosed a milestone in its international phase II trial in critical limb ischemia, which enrolled its 20th patient. Read More
